Preterm Birth and PROM Testing Market

Market Overview: 

The global preterm birth and PROM testing market size reached US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.6 Billion by 2032, exhibiting a growth rate (CAGR) of 5% during 2024-2032. The growing incidences of preterm births across the globe, rising awareness among women about the risks associated with preterm birth and PROM, and innovative advancements in diagnostic technologies are some of the major factors propelling the market.

Preterm birth and premature rupture of membranes (PROM) testing are the diagnostic methods used to assess the risk of preterm birth and PROM during pregnancy. They allow healthcare professionals to identify high-risk pregnancies at an early stage. They also offer valuable information on fetal development, amniotic fluid levels, and signs of premature rupture. They assist in providing enhanced and appropriate interventions and optimizing maternal and neonatal outcomes. Besides this, they aid in improved patient care and management, reduced healthcare costs, and enhanced decision-making and risk assessment.

At present, the rising adoption of preterm birth and PROM testing for early detection of high-risk pregnancies is contributing to the growth of the market. In line with this, the increasing utilization of preterm birth and PROM testing to provide enhanced decision-making to healthcare providers is strengthening the growth of the market. Apart from this, the escalating demand for preterm birth and PROM testing on account of the rising focus on personalized medicines among the masses worldwide is positively influencing the market. Moreover, the increasing utilization of preterm birth and PROM testing due to improved access to prenatal care and diagnostic services across the globe is bolstering the growth of the market. Furthermore, the rising adoption of preterm birth and PROM testing due to the favorable reimbursement policies provided by private healthcare insurance providers around the world is supporting the growth of the market.   

Preterm Birth and PROM Testing Market Trends/Drivers:

Rising incidences of preterm births

There is a rise in the demand for preterm birth and PROM testing due to increasing incidences of preterm births around the world. Women are increasingly facing preterm birth issues on account of the growing number of multiple pregnancies, use of assisted reproductive technologies, and increasing maternal age. Besides this, preterm birth can be caused by numerous lifestyle factors, such as smoking, substance abuse, stress, lack of physical exercise, and improper eating habits among women. Additionally, the prevalence of various medical conditions, such as diabetes and hypertension, among pregnant women is also contributing to the risk of preterm birth. Healthcare providers are increasingly focusing on early screening and testing for preterm birth and PROM to identify high-risk pregnancies, which is positively influencing the market.

Increasing awareness about preterm birth and PROM 

There is an increase in awareness among healthcare providers and pregnant women about the potential risks associated with preterm birth and PROM. Governing agencies, healthcare organizations, and non-profit entities of various countries are taking numerous initiatives to spread awareness among pregnant women and healthcare professionals about the importance of early detection and management of preterm birth. These initiatives include awareness campaigns, educational programs, and guidelines that focus on the value of preterm birth and PROM testing. In addition, women are increasingly preferring screening and testing during prenatal care visits due to the rising awareness about pregnancy issues. Healthcare providers are incorporating these tests into their routine practice, which is contributing to the growth of the market.

Innovative advancements in diagnostic technologies

Various innovative advancements in diagnostic technologies assist in the development of non-invasive and more accurate testing methods. There is a rise in the utilization of fetal fibronectin testing to detect a protein in the cervico-vaginal fluid that provides a reliable marker for predicting the risk of preterm birth. In addition, transvaginal ultrasound assessments of cervical length offer a non-invasive and quantitative approach for evaluating the likelihood of preterm birth. These advancements in diagnostic technologies have improved the accuracy, reliability, and ease of testing, making them more accessible to healthcare providers and pregnant women. Moreover, the wide availability of advanced diagnostic tools and techniques enables timely identification of high-risk pregnancies and better management. 

Preterm Birth and PROM Testing Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global preterm birth and PROM testing market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on test type, application, and end user. 

Breakup by Test Type:

• Pelvic Exam
• Ultrasound
• Biochemical Markers
  • Interleukin (IL)-6
  • C-Reactive Protein (CRP)
  • IL-1, IL-2, IL-8, TNF-a
  • Corticotropin-Releasing Hormone (CRH)
  • Alpha-fetoprotein (AFP)
• Uterine Monitoring
• Nitrazine Test
• Ferning Test
• Pooling
• PAMG-1 Immunoassay
• IGFBP Test
• Fetal Fibronectin (fFN)
• Others  
   

Ultrasound represents the largest market segment

The report has provided a detailed breakup and analysis of the market based on the test type. This includes pelvic exam, ultrasound, biochemical markers [interleukin (IL)-6, C-reactive protein (CRP), IL-1, IL-2, IL-8, TNF-a, corticotropin-releasing hormone (CRH), and alpha-fetoprotein (AFP], uterine monitoring, nitrazine test, ferning test, pooling, PAMG-1 immunoassay, IGFBP test, fetal fibronectin (fFN), and others.  According to the report, ultrasound represented the largest segment.

Ultrasound assists in evaluating the risk of preterm birth and PROM. Ultrasound-based testing comprises the use of high-frequency sound waves to create real-time images of the fetus, cervix, and amniotic fluid. In addition, it provides valuable information on cervical length, fetal development, amniotic fluid levels, and signs of premature rupture. Apart from this, the rising utilization of transvaginal ultrasound to measure cervical length, as a shorter cervix is associated with an increased risk of preterm birth, is contributing to the growth of the market. Furthermore, ultrasound testing is non-invasive and provides real-time imaging capabilities to assess multiple parameters simultaneously.

Breakup by Application:

• PROM
• Preterm Labor
• Chorioamnionitis
   

Preterm labor accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the application. This includes PROM, preterm labor, and chorioamnionitis.  According to the report, preterm labor represented the largest segment.

Preterm labor refers to the onset of labor before 37 completed weeks of gestation that causes risks to both the baby and the mother. It can be caused by various factors, such as infections, multiple pregnancies, previous preterm birth, uterine or cervical abnormalities, and certain medical conditions in the mother. In addition, the rising utilization of preterm birth and PROM testing to assess the risk of preterm birth and facilitate timely interventions is supporting the growth of the market. Various tests used to detect preterm labor are cervical length measurement, fetal fibronectin testing, and other relevant assessments. Moreover, these tests allow healthcare providers to implement strategies to prevent or manage preterm labor.

Breakup by End User:

• Hospitals
• Diagnostic Laboratories
• Others
   

Hospitals hold the biggest market share

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, diagnostic laboratories, and others. According to the report, hospitals represented the largest segment.

Hospitals provide comprehensive healthcare services, such as prenatal care and labor and delivery services. They have medical expertise and resources to conduct a wide range of diagnostic tests and provide appropriate interventions for high-risk pregnancies. There are various departments in hospitals, such as obstetricians, gynecologists, perinatologists, neonatologists, and ultrasound technicians, that specifically test and manage preterm birth and PROM. Apart from this, the rising adoption of hospitals for preterm birth and PROM testing, as they provide specialized care to individuals, is contributing to the growth of the market. 

Breakup by Region:

• North America
  • United States
  • Canada
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

North America exhibits a clear dominance, accounting for the largest preterm birth and PROM testing market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. 

North America held the biggest market share due to the increasing awareness among women about the availability of various testing options. Apart from this, the rising demand for testing services for early detection and management of high-risk pregnancies is contributing to the growth of the market in the region. In line with this, the increasing prevalence of preterm births as compared to other regions is propelling the growth of the market. Furthermore, the presence of key market players that provide innovative diagnostic technologies is bolstering the growth of the market.    

Competitive Landscape:

Key players are introducing new and improved testing methods that assist in providing more accurate and reliable results. In addition, they are focusing on enhancing the sensitivity, specificity, and ease of use of diagnostic tests. Apart from this, major manufacturers are engaging in partnerships and collaborations with healthcare institutions, research organizations, and academic centers to enhance the product development processes and facilitate the efficacy and safety of testing solutions. In line with this, companies are focusing on increasing the accessibility of their testing solutions by forming agreements with healthcare facilities, clinics, and hospitals. Furthermore, they are organizing workshops, webinars, and conferences, to educate healthcare professionals about the importance of preterm birth and PROM testing.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

• Clinical Innovations LLC (Laborie Medical Technologies Inc.)
• Cooper Surgical Inc. (The Cooper Companies Inc.)
• Hologic Inc.
• IQ Products
• NX Prenatal Inc.
• Qiagen N.V
• Sera Prognostics

Preterm Birth and PROM Testing Market Report Scope:

Key Questions Answered in This Report:

• How has the global preterm birth and PROM testing market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global preterm birth and PROM testing market?
• What is the impact of each driver, restraint, and opportunity on the global preterm birth and PROM testing market?
• What are the key regional markets?
• Which countries represent the most attractive preterm birth and PROM testing market?
• What is the breakup of the market based on the test type?
• Which is the most attractive test type in the preterm birth and PROM testing market?
• What is the breakup of the market based on the application?
• Which is the most attractive application in the preterm birth and PROM testing market?
• What is the breakup of the market based on the end user?
• Which is the most attractive end user in the preterm birth and PROM testing market?
• What is the competitive structure of the global preterm birth and PROM testing market?
• Who are the key players/companies in the global preterm birth and PROM testing market?

Key Benefits for Stakeholders:

• IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the preterm birth and PROM testing market from 2018-2032.
• The research study provides the latest information on the market drivers, challenges, and opportunities in the global preterm birth and PROM testing market.
• The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the preterm birth and PROM testing industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.